Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
卡瑞利珠单抗联合阿帕替尼和替莫唑胺作为晚期肢端黑色素瘤患者的一线治疗:CAP 03 II期非随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.1363
Mao, Lili; Lian, Bin; Li, Caili; Bai, Xue; Zhou, Li; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Wang, Xuan; Tang, Bixia; Yan, Xieqiao; Li, Siming; Kong, Yan; Dai, Jie; Wei, Xiaoting; Li, Juan; Duan, Rong; Xu, Huayan; Wu, Xiaowen; Yang, Yue; Cheng, Fengzhuo; Zhang, Cheng; Xia, Fangzhou; Pang, Zheng; Guo, Jun; Si, Lu